JUPITER — Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps ...

Eating carefully and exercising regularly, yet the scale refuses to move? Thyroid health could be the missing link. As ...

Alveus Therapeutics has debuted with $160m in Series A financing, as the biotech looks to join the crowded obesity sector ...

In the battle of the breakfast bowls, one grain reigns supreme for metabolic health, muscle repair, and long-term satiety—and ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based ...

Type 2 diabetes quietly changes the heart structure and how it produces energy, thus increasing the risk of heart failure, ...

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive prelimi ...

Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...

The large nonprofit health system, based in Philadelphia, is suing multiple companies, saying they colluded to raise the price of insulin, which in turn forced the health system to spend more on ...

Over 75 home cooks have given this grain-free recipe five stars. Here is why it’s the ultimate fix for your morning energy ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...